Literature DB >> 10544610

[Incidence of cardiovascular risk factors and complications after kidney transplantation].

K Ivens1, S Aker, B Grabensee, P Heering.   

Abstract

BACKGROUND: Cardiovascular disease is a leading cause of death after renal transplantation (RTx), and the incidence is considerably higher than in the general population. Aim of this study was to evaluate the incidence of atherosclerotic cardiovascular complications after RTx, the prevalence of cardiovascular risk factors, prior to and following RTx, and the association between the risk factors and complications. PATIENTS AND METHODS: Analysis of atherosclerotic cardiovascular diseases (coronary artery disease, cerebral and peripheral vascular disease) and cardiovascular risk factors before and after transplantation in 427 renal transplant recipients between 1987 and 1992 (mean age at transplantation 45 +/- 12 years, 58% male, 7% diabetics) with a mean posttransplant follow-up of 28 +/- 20 months.
RESULTS: Following RTx 11.7% developed atherosclerotic cardiovascular diseases, the majority coronary artery disease (9.8%). The comparison of risk factors 12 months before and 24 months following transplantation showed: The prevalence of systemic hypertension (from 67% to 86%), diabetes mellitus (from 7% to 16%) and obesity with a body mass index > 25 kg/m2 (from 26% to 48%) had increased significantly whereas the number of smokers halved to 20%. The triglycerides decreased significantly (from 235 +/- 144 mg/dl to 217 +/- 122 mg/dl). The total and HDL cholesterol rose significantly (from 232 +/- 65 mg/dl to 273 +/- 62 mg/dl and from 47 +/- 29 mg/dl to 56 +/- 21 mg/dl, respectively). The LDL cholesterol increase was insignificant (from 180 +/- 62 mg/dl to 189 +/- 53 mg/dl). In the univariate analysis, cardiovascular diseases were significantly associated with male gender, age over 50 years, diabetes mellitus (DM), smoking, total cholesterol > 200 mg/dl, LDL cholesterol > 180 mg/dl, HDL cholesterol < 55 mg/dl, fibrinogen > 350 mg/dl, body mass index > 25 kg/m2, and more than 2 antihypertensive agents per day. The Cox proportional hazards model revealed DM with a relative risk (RR) of 4.3, age > 50 years (RR = 2.7), body mass index > 25 kg/m2 (RR = 2.6), smoking (RR = 2.5), and LDL cholesterol > 180 mg/dl (RR = 2.3) as independent risk factors.
CONCLUSIONS: The high incidence of cardiovascular disease following renal transplantation is mainly due to a high prevalence and accumulation of classical risk factors before and following transplantation. The treatment of the risk factors must be effective and introduced early in the course of renal failure, further, they must be continued following transplantation. Future prospective studies should evaluate the success of treatment regarding reduction of cardiovascular morbidity and mortality in this high risk population.

Entities:  

Mesh:

Year:  1999        PMID: 10544610     DOI: 10.1007/bf03044939

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  20 in total

1.  Report on management of renal failure in Europe, XXII, 1991.

Authors:  A E Raine; R Margreiter; F P Brunner; J H Ehrich; W Geerlings; P Landais; C Loirat; N P Mallick; N H Selwood; G Tufveson
Journal:  Nephrol Dial Transplant       Date:  1992       Impact factor: 5.992

2.  Changes in causes of death after renal transplantation, 1966 to 1987.

Authors:  M N Hill; R A Grossman; H I Feldman; S Hurwitz; D C Dafoe
Journal:  Am J Kidney Dis       Date:  1991-05       Impact factor: 8.860

3.  Follow-up of lipid and apoprotein levels in renal transplant recipients.

Authors:  M R Averna; C M Barbagallo; V Sparacino; F Caputo; C Mancino; S Calabrese; A Notarbartolo
Journal:  Nephron       Date:  1991       Impact factor: 2.847

4.  Lovastatin treatment of hypercholesterolemia in renal transplant recipients.

Authors:  B L Kasiske; K L Tortorice; K L Heim-Duthoy; J M Goryance; K V Rao
Journal:  Transplantation       Date:  1990-01       Impact factor: 4.939

Review 5.  Hyperlipidemia in solid organ transplantation.

Authors:  J A Kobashigawa; B L Kasiske
Journal:  Transplantation       Date:  1997-02-15       Impact factor: 4.939

6.  Renal transplantation: complications and results in the second decade.

Authors:  K V Rao
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

7.  Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.

Authors:  N Yoshimura; Y Ohmori; T Tsuji; T Oka
Journal:  Transplant Proc       Date:  1994-10       Impact factor: 1.066

8.  The adverse impact of cyclosporine on serum lipids in renal transplant recipients.

Authors:  B L Kasiske; K L Tortorice; K L Heim-Duthoy; W M Awni; K V Rao
Journal:  Am J Kidney Dis       Date:  1991-06       Impact factor: 8.860

9.  Cyclosporine, low-density lipoprotein, and cholesterol.

Authors:  P C de Groen
Journal:  Mayo Clin Proc       Date:  1988-10       Impact factor: 7.616

10.  Late mortality and morbidity in recipients of long-term renal allografts.

Authors:  R L Kirkman; T B Strom; M R Weir; N L Tilney
Journal:  Transplantation       Date:  1982-12       Impact factor: 4.939

View more
  1 in total

1.  Death with functioning kidney transplant: an obituarial analysis.

Authors:  Puneet Sood; Yong R Zhu; Eric P Cohen
Journal:  Int Urol Nephrol       Date:  2010-06-03       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.